Sultamicillin 750mg Dosing
For adult community-acquired infections, sultamicillin 750 mg should be administered orally twice daily (every 12 hours), with dose reduction required for patients with significant renal impairment (creatinine clearance <30 mL/min). 1
Standard Adult Dosing
The recommended adult dose is 750 mg twice daily for most community-acquired infections including:
- Upper and lower respiratory tract infections
- Urinary tract infections
- Skin and soft tissue infections
This twice-daily regimen provides effective therapy while offering better compliance compared to three-times-daily alternatives 3. The 750 mg dose delivers ampicillin 500 mg plus sulbactam 250 mg as a mutual prodrug combination.
Pediatric Dosing
For children, the recommended dose is 50 mg/kg/day divided into two doses (approximately 25 mg/kg twice daily) 2. This is particularly appropriate for otitis media given the prevalence of beta-lactamase-producing Haemophilus influenzae and Branhamella catarrhalis.
Renal Impairment Adjustments
Dose reduction is essential in renal impairment because both ampicillin and sulbactam are renally cleared with similar elimination kinetics 1, 4. Based on the FDA-approved ampicillin/sulbactam IV formulation (which sultamicillin converts to after absorption):
- CrCl ≥30 mL/min: No adjustment needed - 750 mg every 12 hours
- CrCl 15-29 mL/min: Reduce frequency to 750 mg every 24 hours
- CrCl 5-14 mL/min: Further reduce to 750 mg every 24 hours (consider lower dose)
- Hemodialysis patients: 750 mg every 24 hours, administered after dialysis on dialysis days
The half-life more than doubles in severe renal failure (from ~1 hour to >13 hours for sulbactam), making dose adjustment critical to avoid drug accumulation 4, 5.
Administration Considerations
- Take with or without food - administration with meals may improve GI tolerability 2
- Duration: Typically 7-10 days depending on infection type 6, 7
- Well tolerated - diarrhea/loose stools are the most common side effect but rarely require discontinuation 2
Clinical Context
The 750 mg twice-daily dose achieves peak ampicillin serum concentrations of approximately 9-14 mg/L within 1 hour, which is adequate for most community-acquired pathogens 7. The beta-lactamase inhibitor sulbactam component provides coverage against beta-lactamase-producing organisms that would otherwise be ampicillin-resistant 2, 6.
Important caveat: In critically ill patients or those with augmented renal clearance, standard dosing may be insufficient and therapeutic drug monitoring should be considered 5, 8. Conversely, patients with acute kidney injury are at high risk for drug accumulation even with dose adjustments 5.